CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ra Pharmaceuticals today announced that Doug Treco, PhD, President and Chief Executive Officer, will present at the Cowen and Company 36th Annual Health Care Conference on Monday, March 7, 2016 at 3:00 p.m. E.T. The conference is being held at the Boston Marriott Copley Place.
About Ra Pharmaceuticals
Ra Pharma combines novel insights into innate immunity with leadership in macrocycle technology to transform the lives of patients with life-threatening disorders. Our proprietary Extreme Diversity™ peptide chemistry platform delivers drugs with the diversity and specificity of antibodies, coupled with the pharmacological properties of small molecules. Our primary clinical focus is on diseases of complement dysregulation and orphan indications defined by validated biomarkers. For more information, please visit: www.rapharma.com,